{"id":3409,"date":"2018-10-17T15:53:26","date_gmt":"2018-10-17T14:53:26","guid":{"rendered":"https:\/\/lscconnect.com\/consultantconnect\/what-does-brexit-mean-for-the-life-science-industry\/"},"modified":"2020-12-15T17:27:40","modified_gmt":"2020-12-15T17:27:40","slug":"what-does-brexit-mean-for-the-life-science-industry","status":"publish","type":"post","link":"https:\/\/lscconnect.com\/consultantconnect\/blog\/2018\/10\/17\/what-does-brexit-mean-for-the-life-science-industry\/","title":{"rendered":"What does Brexit mean for the Life Science industry?"},"content":{"rendered":"
Brexit is a hot topic in the news at the moment, but what does it mean for the Life Science industry?<\/p>\n
While the eventual outcome and effects of Brexit (Deal\/No-Deal) are still unclear there is certainly a lot of concern and anxiety in the Pharma and Biotech sector surrounding the impact of Brexit on the industry. What will Brexit mean for medicine supply, capital investment, cross border collaboration and movement of researchers?<\/p>\n
Below we look at some commentary around the web concerning Brexit and it\u2019s potential impact on the Life Science sector.<\/p>\n
Headline: Astrazeneca halts UK investment due to Brexit uncertainties Headline: Clinical Trials plummet in the UK as Brexit looms<\/strong> Headline: Where does Brexit leave European Biotech?<\/strong> Headline: Pfizer estimates its Brexit costs will reach $100m<\/strong>
\n<\/strong>AstraZeneca has suspended investments in Britain due to the lack of clarity over the country’s departure from the European Union, the pharmaceutical firm’s non-executive chairman Leif Johansson told France’s Le Monde newspaper. Click here for the full article>><\/a><\/p>\n
\nAn interesting article that suggests a 25% year on year (2016 to 2017) drop in UK clinical trials is related to Brexit regulatory approval concerns. Click here for the full article>><\/a><\/p>\n
\nThis high-level article covers all the angles of Brexit and the European Biotech sector. Click here for the full article>><\/a><\/p>\n
\n.\u00a0significant number of Pharma\/Biotech companies flag the risks and costs associated with Brexit.\u00a0Click here for the full article>><\/a><\/p>\n